Drug · DIN 02273217
ENABLEX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 2, 2019; first marketed April 6, 2006.
- Drug Identification Number (DIN)
- 02273217
- Company (DIN owner)
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Darifenacin G04BD10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DARIFENACIN (DARIFENACIN HYDROBROMIDE) | 7.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 11, 2019: NOC 21842New Drug Submission (NDS) · A change in product ownership from mjerus labs to searchlight pharma inc., and to add a pvc-pvdc with aluminum foil blister pack of 7 tablets for the 7.5 mg tablet
- April 16, 2013: NOC 14290New Drug Submission (NDS) · Manufacturer name change
- November 14, 2005: NOC 7610New Drug Submission (NDS)
Other DINs named ENABLEX
- DIN 02273225 · Marketed